PIIINP

2 papers1 finding

Humans1
Animals1

Interventions

1

SGLT2 inhibitors

downin humans1

1 study

SGLT2 inhibitors decrease PIIINP in humans (15.1% vs. 5.8%).
Humansin patients with HFpEF6 months
Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis
Frontiers in cardiovascular medicine21 Jul 2026

More on SGLT2 inhibitors

Latest

3 in 12 months

Experimental Neurology17 Aug

Pathological α-synuclein propagation via the gut-liver axis induces liver injury in gut-origin Parkinson's disease mouse models

Experiments in miceGut and microbiome

Frontiers in Cardiovascular Medicine5 Aug

Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

Cohort study of 185 peopleSGLT2 inhibitors

GSA 2025 Abstract3 Jan

Association of Urinary Biomarkers and Joint Longitudinal Cognitive-Gait Trajectories: Health ABC Findings

Study in peopleBiomarkers